At its roots, Sigma Chi Fight Night is a philanthropy event. While the growing popularity in recent years has enabled us to expand the production, it has also enabled the Alpha Nu Chapter to gift large donations to our worthy benefactors. This event alone has raised over $200,000 for charity since 2014. Despite unprecedented success in recent years, however, we are confident that this year's event will be the biggest and best yet. We have set our most ambitious fundraising goal in the rich history of the event at $100,000 this year. With the outstanding support and generosity of our sponsors, attendees, and fighters, our brothers look forward to achieving this goal. Read below to learn more about our beneficiaries for Fight Night 2017.
This Year's Beneficiaries
Founded by Jon M. Huntsman Sr., an alumnus of the Sigma Chi Fraternity, the Huntsman Cancer Institute (HCI) was chosen as the sole preferred philanthropic partner of Sigma Chi in December 2012. On April 12, 2013 both organizations celebrated the one millionth dollar donated by Sigma Chi to HCI, a significant milestone in a partnership working toward a cure for cancer. The American Cancer Society estimates that 1 in 2 men and 1 in 3 women will be affected by cancer in his or her lifetime, and it is the second leading cause of death in United States. Sigma Chi and HCI hope to eradicate this disease through research and treatment breakthroughs made possible by donations, such as funds raised from Texas Fight Night.
The Andrew McDonough B+® Foundation was created to honor a 14-year-old star -- on and off the soccer field. He bravely battled leukemia with his "Be Positive" attitude and B+ blood type, never leaving the hospital for 167 days, and earned his spot in heaven in July 2007. The B+ Foundation spreads Andrew's positive attitude and zest for life, and has changed the way thousands of families relate to each other. The B+ Foundation provides financial assistance to families of children with cancer nationwide as well as funds critical pediatric cancer research to find cures for childhood cancers and improve chemotherapy.